Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174275 | SCV000225552 | uncertain significance | not provided | 2014-12-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001423715 | SCV001626297 | likely benign | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000174275 | SCV002072736 | likely benign | not provided | 2021-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002516624 | SCV003688655 | uncertain significance | Inborn genetic diseases | 2021-08-23 | criteria provided, single submitter | clinical testing | The c.1116C>A (p.S372R) alteration is located in exon 12 (coding exon 10) of the CC2D2A gene. This alteration results from a C to A substitution at nucleotide position 1116, causing the serine (S) at amino acid position 372 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |